RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Nuove frontiere nella stratificazione delle leucemie acute linfoidi (LAL): integrazione tra citogenetica non-convenzionale, genomica e post-genomica
• 2 - Studio delle basi molecolari per un'ottimizzazione della terapia mirata con inibitori delle tirosin-kinasi: il caso della leucemia mieloide cronica e di altre neoplasie ematologiche
• 3 - Patogenesi molecolare ed analisi sequenziale di interazioni cellulari e marcatori biologici di progressione di malattia e di resistenza al trattamento nella leucemia linfatica cronica
• 4 - Sindromi Mielodisplastiche: modelli patogenetici e nuove possibilità terapeutiche
• 5 - Studio delle basi molecolari e cellulari della risposta alla terapia mirata con inibitori delle tirosin-kinasi per l'ottimizzazione del trattamento delle leucemia Philadelphia positive
• 6 - Meccanismi di leucemogenesi e terapia target nelle sindromi Mielodisplastiche e nelle Leucemie Acute Mieloidi
• 7 - PROGRESSIONE DA MGUS A MIELOMA MULTIPLO: PATOGENESI MOLECOLARE, IDENTIFICAZIONE DI POTENZIALI MARCATORI PROGNOSTICI E SVILUPPO PRECLINICO DI RAZIONALI APPROCCI CHEMIOPREVENTIVI
• 8 - Metastasi epatiche da cancro del colon-retto: fattori di rischio, prognosi e trattamento su basi molecolari
• 9 - RUOLO DELLA FARMACOGENETICA NELLA DEFINIZIONE DELL'ATTIVITA' E TOLLERABILITA' DELLA CHEMIOTERAPIA ANTINEOPLASTICA
• 10 - Patogenesi molecolare dei linfomi in funzione della terapia

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • GENETICA MEDICA
  • MALATTIE DEL SANGUE
  • PEDIATRIA GENERALE E SPECIALISTICA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Lombardia

Bibliografia

Selected references
Pui C-H et al., Hematology (Am Soc Hematol Educ Program) 2004:118-145.
Richard M. et al.,Hematology (Am Soc Hematol Educ Program) 2004:98-117.
Gilliland RD et al., Hematology (Am Soc Hematol Educ Program) 2004:80-97.
Haferlach T et al., Semin Hematol. 2003;40:281-95
Cario G et al., Blood. 2005;105:821-6.
Holleman A et al., N Engl J Med. 2004;351:533-42.
Tartaglia M et al., Blood. 2004;104:307-13.
Gilliland DG et al., Hematology (Am Soc Hematol Educ Program) 2004;80-97.
Tartaglia M et al., Br J Haematol, 2005, in press.
Falini B et al., N Engl J Med. 2005;352:254-66.
Brambillasca F et al., Leukemia 13: 369-375, 1999.
Pui CH, et al. Acute lymphoblastic leukemia. N Engl J Med, 350:1535-48, 2004.
Faderl S, et al. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood, 91:3995-19, 1998.
Gokbuget N, Hoelzer D. Recent approaches in acute lymphoblastic leukemia in adults. Rev Clin Exp Hematol, 6: 114-41, 2002.
Yeoh EJ, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell, 1:133-43, 2002.
Fine BM, et al. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood, 103:1043-9, 2004.
Chiaretti S, et al. Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood, 103:2771-8, 2004.
Chiaretti S, et al. Gene Expression Profiles of B-lineage Adult Acute Lymphocytic Leukemia Reveal Distinct Genetic Patterns that Identify Lineage and Distinct Mechanisms of Transformation. Submitted
Kohlmann A, et al. Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. Leukemia, 18:63-71, 2004.
Cazzaniga G, et al. Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response. Br J Haematol, 19:445-53, 2002.
Scrideli CA, et al. Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia. Leukemia, 11:2234-7, 2003.
Foa R, et al. E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features. Br J Haematol, 120:484-7, 2003.
Hunger SP. Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood, 87:1211-24, 1996.
Petricoin et al. Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov 1:683–695, 2002.
B Martin et al. From genomics to proteomics: techniques and applications in cancer research. Trends Cell Bio 11:S60–S65, 2001.
Templin et al. Protein microarray technology. Trends Biotechnol 20:160–166, 2002.
Paweletz et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20:1981–1989, 2001.
Wulfkuhle et al. Proteomic applications for the early detection of cancer. Nat Rev Cancer 3:267–275. 2003.
Liotta et al. Clinical proteomics: personalized molecular medicine. J Am Med Assoc 286:2211–2214, 2001.
MacBeath, Protein microarrays and proteomics. Nat Genet 32:526–532, 2002.
MacBeath et al. Printing proteins as microarrays for high-throughput function determination. Science 289 5485:1760–1763, 2000.
Tallman MS. Relevance of pathologic classifications and diagnosis of acute myeloid leukemia to clinical trials and clinical practice. Cancer Treat.Res. 2004; 121: 45-67.
Valk PJ, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N.Engl.J.Med. 2004; 350: 1617-28.
Bullinger L, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N.Engl.J.Med. 2004; 350: 1605-16.
Yagi T, et al. Identification of a gene expression signature associated with pediatric AML prognosis. Blood 2003; 102: 1849-56.
Moreau Y, et al. Comparison and meta-analysis of microarray data: from the bench to the computer desk. Trends Genet. 2003; 19: 570-7.
Parmigiani G, et al. Molecular classification of lung cancer: a cross-platform comparison of gene expression data sets. CHEST 2004; 125: 103S.
Rhodes DR, et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc.Natl.Acad.Sci.U.S.A 2004; 101: 9309-14.
Bicciato S. Artificial neural network technologies to identify biomarkers for therapeutic intervention. Curr.Opin.Mol.Ther. 2004; 6: 616-23.
Bicciato S, et al. Marker identification and classification of cancer types using gene expression data and SIMCA. Methods Inf.Med. 2004; 43: 4-8.
Bicciato S, et al. PCA disjoint models for multiclass cancer analysis using gene expression data. Bioinformatics. 2003; 19: 571-8.
Bicciato S, et al. Pattern identification and classification in gene expression data using an autoassociative neural network model. Biotechnol.Bioeng. 2003; 81: 594-606.
MM O’Gorman and TG Cotter. Molecular signals in anti-apoptotic survival pathways. Leukemia, 2001; 15: 21-34.
F. Casale, et al. Determination of the in vivo effects of prednisone on Bcl-2 family protein expression in childhood acute lymphoblastic leukemia. International Journal of Oncology, 2003; 22: 123-128,.
R. Addeo, et al. Indolfi. Prognostic Role of bcl-xL and p53 in Childhood Acute Lymphoblastic Leucemia. Cancer Biol.& Therapy, 2005; 4: in press.
RG Jones, et al. Protein Kinase B regulated T lymphocite survyval nuclear factor kB and Bcl-xl levels in vivo. J Exp Med 2000, 191: 1721-1733.
X Tang, et al. Role of phosphatidylinositol 3-kinase and specific protein kinase B isoforms in the suppression of apoptosis mediated by Abelson protein-tyrosine kinase. J Biol Chem 2000, 275: 13142-13148.
Y Leverrier, et al. Role of PI3-kinase in Bcl-x induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-9 cells. Cell Death Differen, 1999, 6: 290-298.
CM Horvarth. STAT proteins and transcriptional responses to extracellular signals. TIBS, 2000; 25: 495-502.
R Buettner, et al. Activated STAT signalling in human tumors provides novel molecular targets for therapetic intervention. Clin Cancer Res, 2002; 8:945-954
JB Demoulin, et al. STAT5 activation is required for interleukin-9-dependent growth and trasformation of lymphoid cells. Cancer Res., 2000; 60: 3971-3977.
K Kirito, et al. Thrombopoietin regulates Bcl-xl expression through Stat5 and phosphatidylinositol-3-kinase activation pathways.J Biol Chem, 2002; 277: 8329-8337.
J Turkson, et al. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell, 1994; 77: 63–71
Hammerman PS, et al. The Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood. 2005 Feb 10
Deutsch E, et al. Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation. Br J Cancer. 2004, 91: 1735-41.
Solit DB, et al. Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol. Cancer Res. 2003 63: 2139-44.
Chakraborty, A., et al. Granulocyte colony-stimulating factor activation of Stat3 a and Stat3 b in immature normal and leukemic human myeloid cells. Blood, 1996; 88: 2442–2449.
Drexler HG, et al. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations. Leukemia, 2004; 18: 227-232.
Xi S, et al. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy. Oncogene. 2005 Feb 3;24(6):970-9
Lee YK, et al.VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.Leukemia. 2005 Feb 10

Parole Chiave

LEUCEMIA PEDIATRICA; PROFILO DI ESPRESSIONE GENICA; PROTEOMICA